Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
Learn more
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Learn more
Announcing Investor Connect Plus: A LaunchBio x…
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Statement on China Approvals of Agricultural Biotechnology Products
January 17, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement on the announcement that the People’s Republic of China’s National Biosafety Committee approved the final safety certificate for five…
New Platform for Innovation in Food and Agriculture Launches, Invites Broad Conversation
January 16, 2019
WASHINGTON, DC – Jan. 16, 2019 – Today, the Biotechnology Innovation Organization (BIO) and the American Seed Trade Association (ASTA) jointly announce the launch of Innovature, a new platform to spark a thoughtful dialogue around innovation in food…
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
January 11, 2019
“Members of the House have sent a strong signal to the American people about their commitment to prioritizing health security by providing the resources needed to fully prepare for and defend against biological threats. Strengthening the pipeline of…
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
December 20, 2018
Washington, DC (December 20, 2018) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement applauding passage today by the House of Representatives of the Pandemic and All-Hazards…
BIO Statement on USDA Finalizing Rule for National Bioengineered Food Disclosure Standard
December 20, 2018
The Biotechnology Innovation Organization today released the following statement in response to USDA issuing a final rule implementing the National Bioengineered Food Disclosure Standard: 
BIO Statement on Hatch-Waxman Integrity Act of 2018
December 14, 2018
“For almost 40 years, the groundbreaking law known as the Hatch-Waxman Act (HWA) has been highly successful in spurring the development of life-saving new treatments while at the same time vastly broadening the availability of low-cost generic…
BIO Applauds Bipartisan 2018 Farm Bill
December 11, 2018
Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the 2018 Farm Bill:
BIO Commends Signing of the United States-Mexico-Canada Agreement
November 30, 2018
Washington, D.C. (November 30, 2018) – Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):“The signing of today’s trade…
BIO Statement on EPA Finalizing RFS Volumes for 2019
November 30, 2018
Brent Erickson, Executive Vice President of the Biotechnology Innovation Organization’s (BIO) Industrial and Environmental Section, released the following statement today on final Renewable Fuel Standard (RFS) volumes for 2019 and the Biomass-Based…
BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation
November 28, 2018
“I applaud Chairman Brady and his colleagues on the House Ways & Means Committee for recognizing the unintended consequences faced by far too many small business innovators today due to NOL limitations."